Some studies report weight loss of up to 15% of body weight over a year when semaglutide is taken consistently and combined with lifestyle changes
Ozempic is a brand-name version of semaglutide prescribed for type 2 diabetes, while Wegovy (another semaglutide brand) is FDA-approved for weight loss
[5] Why Manufacturers Keep Feeding the System They Complain About Pharmaceutical manufacturers are not reluctant participants in the PBM system
Nat Commun 13(1):684 Xu G, Kaneto H, Laybutt DR, Duvivier-Kali VF, Trivedi N, Suzuma K et al (2007) Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes
You may be a candidate if: BMI 30+ (obese), OR BMI 27+ with diabetes, high blood pressure, high cholesterol, or sleep apnea Diet and exercise alone haven't worked Who should not use GLP-1 medications: History of medullary thyroid cancer or MEN 2 syndrome Pregnant or breastfeeding History of severe pancreatitis We'll confirm your eligibility during your consultation
Cancer 19 (1), 50